Search Results - "Pereira, Sharlene L"

Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists by Zapata-Sudo, Gisele, Lima, Lídia M, Pereira, Sharlene L, Trachez, Margarete M, da Costa, Filipe P, Souza, Beatriz J, Monteiro, Carlos E S, Romeiro, Nelilma C, D'Andrea, Éverton D, Sudo, Roberto T, Barreiro, Eliezer J

“…Diabetes is a metabolic disorder characterized by hyperglycemia. When not properly controlled, complications include neuropathy, coronary artery disease, and…”
Get more information

Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline‐induced pulmonary hypertension in rats by Alencar, Allan K N, Pereira, Sharlene L, Montagnoli, Tadeu L, Maia, Rodolfo C, Kümmerle, Arthur E, Landgraf, Sharon S, Caruso‐Neves, Celso, Ferraz, Emanuelle B, Tesch, Roberta, Nascimento, José H M, Sant'Anna, Carlos M R, Fraga, Carlos A M, Barreiro, Eliezer J, Sudo, Roberto T, Zapata‐Sudo, Gisele

“…Background and Purpose Pulmonary arterial hypertension (PAH) is characterized by enhanced pulmonary vascular resistance, right ventricular hypertrophy and…”
Get full text

N -acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity by Alencar, Allan K.N, Pereira, Sharlene L, da Silva, Flavia E, Mendes, Luiza V.P, Cunha, Valéria do M.N, Lima, Lidia M, Montagnoli, Tadeu L, Caruso-Neves, Celso, Ferraz, Emanuelle B, Tesch, Roberta, Nascimento, José H.M, Sant'Anna, Carlos M.R, Fraga, Carlos A.M, Barreiro, Eliezer J, Sudo, Roberto T, Zapata-Sudo, Gisele

“…Abstract Background Pulmonary arterial hypertension (PAH) is a disease that results in right ventricular (RV) dysfunction. While pulmonary vascular disease is…”
Get full text

Pharmacological Characterization of (3-Thienylidene)-3,4-Methylenedioxybenzoylhydrazide: A Novel Muscarinic Agonist With Antihypertensive Profile by Zapata-Sudo, Gisele, Pereira, Sharlene L., Beiral, Hellen J.V., Kummerle, Arthur E., Raimundo, Juliana M., Antunes, Fernanda, Sudo, Roberto T., Barreiro, Eliezer J., Fraga, Carlos A.M.

“…Background Several new bioactive compounds of the N-acylhydrazone class were developed from the safrole, a Brazilian natural product obtained from sassafras…”
Get full text

PM391 Improvement Of Vascular And Cardiac Remodeling By Benzoylhydrazone Derivative In Rats With Monocrotaline-Induced Pulmonary Hypertension by Zapata-Sudo, Gisele, Leal, Carla M, Leal, Daniella M, Pereira, Sharlene L, Ferraz, Emanuelle B, Fraga, Carlos A, Nascimento, Jose H, Barreiro, Eliezer J, Sudo, Roberto T

Get full text

PM390 Recovery Of Vascular And Ventricular Dysfunction By A New N-Acylhydrazone Derivative In Experimental Pulmonary Hypertension by Zapata-Sudo, Gisele, Alencar, Allan K, Pereira, Sharlene L, Tesch, Roberta, Silva, Flavia E, Cunha, Valeria N, Barreiro, Eliezer J, Nascimento, Jose H, Fraga, Carlos A, Sudo, Roberto T

Get full text

Oral treatment with Euterpe oleracea Mart. (açaí) extract improves cardiac dysfunction and exercise intolerance in rats subjected to myocardial infarction by Zapata-Sudo, Gisele, da Silva, Jaqueline S, Pereira, Sharlene L, Souza, Pergentino J C, de Moura, Roberto S, Sudo, Roberto Takashi

“…This study was designed to evaluate the cardioprotective effects of Euterpe oleracea Mart., popularly known as "açaí", on rats subjected to myocardial…”
Get full text

Abstract 059: N-acylhydrazone Derivative Improves Cardiac Hypertrophy and Dysfunction in Spontaneously Hypertensive Rats Submitted to Myocardial Infarction by Zapata-Sudo, Gisele, Silva, Jaqueline S, Pereira, Sharlene L, Maia, Rodolfo C, Fraga, Carlos A, Barreiro, Eliezer J, Sudo, Roberto T

“…Abstract only Aims: Ventricular dysfunction is observed in arterial hypertension and myocardial infarction (MI). The N -acylhydrazone derivative,…”
Get full text

Abstract 329: Oral Administration of New Calcium Channel Antagonist Reverses Right Ventricular Dysfunction in Rats With Pulmonary Arterial Hypertension by Pereira, Sharlene L, Alencar, Allan K, Kummerle, Arthur E, Ferraz, Emanuelle B, Nascimento, José, Fraga, Carlos A, Barreiro, Eliezer J, Sudo, Roberto T, Zapata-Sudo, Gisele

“…Abstract only Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance, endothelial injury and vascular remodeling,…”
Get full text

Abstract 058: Novel Agonist of Adenosine Receptor Ameliorates Ventricular and Vascular Dysfunction in Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Zapata-Sudo, Gisele, Alencar, Allan K, Pereira, Sharlene L, Ferraz, Emanelle, Nascimento, José H, Tesch, Roberta, Maia, Rodolfo, Sant’Anna, Carlos M, Fraga, Carlos A, Barreiro, Eliezer J, Sudo, Roberto T

“…Abstract only Aims: Pulmonary arterial hypertension (PAH) consists of increased pulmonary vascular resistance and remodeling and right ventricular hypertrophy…”
Get full text

Abstract 532: New Agonist of A2a Receptor Reduces Ventricular and Vascular Dysfunction in Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Alencar, Allan K, Pereira, Sharlene L, Kummerle, Arthur E, Langraf, Sharon S, Caruso-Neves, Celso, Baptista, Emanuelle F, Nascimento, José, Barreiro, Eliezer J, Fraga, Carlos A, Sudo, Roberto T, Zapata-Sudo, Gisele

“…Abstract only Pulmonary arterial hypertension (PAH) is characterized by enhanced pulmonary vascular resistance with subsequent remodeling and right ventricular…”
Get full text

Beneficial effects of a novel agonist of the adenosine A 2A receptor on monocrotaline‐induced pulmonary hypertension in rats by Alencar, Allan K N, Pereira, Sharlene L, Montagnoli, Tadeu L, Maia, Rodolfo C, Kümmerle, Arthur E, Landgraf, Sharon S, Caruso‐Neves, Celso, Ferraz, Emanuelle B, Tesch, Roberta, Nascimento, José H M, de Sant'Anna, Carlos M R, Fraga, Carlos A M, Barreiro, Eliezer J, Sudo, Roberto T, Zapata‐Sudo, Gisele

“…Background and Purpose Pulmonary arterial hypertension (PAH) is characterized by enhanced pulmonary vascular resistance, right ventricular hypertrophy and…”
Get full text